Clinical Trial Update: A Trial of Fimasartan for Early Diastolic Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial of fimasartan for hypertension and early diastolic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Hypertension

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: Asan Medical Center | Conditions: Hypertension | Phase 4 | Status: COMPLETED